Skip to content
Search

Latest Stories

Government launches £140m AI award to fast-track innovation

The health secretary has launched a £140 million artificial intelligence (AI) award to fast-track life-saving innovation to the NHS.

Companies are being encouraged to bid for a share of the amount to launch their AI innovation across the health service. The funding will be awarded based on a project’s potential to save lives and free up staff time and help deliver.


The award was announced today by Health Secretary Matt Hancock at a Parliament and HealthTech Conference event.

"This whole agenda is not about technology, it’s about people. The best kind of tech is the technology you barely notice because it just works, he said, adding: "It’s the kind of tech that helps humanise a difficult and demanding environment, by freeing you up to do more of the work you love."

Hancock said that the government was aiming to give back clinicians the "gift of time  and allowing them to care."

"It’s what clinicians are crying out for, it’s what patients expect and it’s what will bring our NHS into the 21st century," he added.

The award will form part of the £250 million AI Lab announced by Prime Minister Boris Johnson last year and will be run by the Accelerated Access Collaborative in partnership with NHSX.

Simon Stevens, NHS Chief Executive, said: “From helping to personalise NHS screening and treatments for cancer, eye disease and a range of other conditions, the possibilities that AI could help with are vast and the NHS is already ramping up the use of world-leading technology as part of our Long Term Plan”.

The first call for applications is open from today until the next five weeks.

AI is already in use across the NHS, successfully predicting cancer survival rates and cutting the number of missed appointments. In the East Midlands alone, AI scans five million people, helping to predict breast cancer sooner.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less